Furthermore, ApoD may serve as a glial marker of AD progression since studies on AD patients have shown increased levels of ApoD expression in both neurons and glial cells in the hippocampus, cerebral cortex, and CSF, regardless of gender. This evidence concerns the gene APOD and Alzheimer disease.